Filter
1659
Filtered Results: 1659
Text search:
drug
financing
Featured
Recommendations
109
New Publications
567
Language
Document type
No document type
1088
Studies & Reports
265
Guidelines
111
Strategic & Response Plan
91
Manuals
43
Situation Updates
35
Fact sheets
13
Training Material
7
Infographics
5
Resource Platforms
1
Countries / Regions
Kenya
74
Global
69
Uganda
55
Sierra Leone
49
Ethiopia
48
Nigeria
47
Liberia
46
Western and Central Europe
45
Malawi
40
India
40
Nepal
38
Zambia
37
Ghana
34
South Africa
30
Myanmar / Burma
30
Africa
29
Tanzania
28
Bangladesh
28
Rwanda
27
Eastern Europe
27
Asia
24
Cambodia
22
Ukraine
20
Namibia
20
Philippines
18
Latin America and the Carribbean
18
Lesotho
15
Botswana
15
South–East Asia Region
14
Zimbabwe
12
Senegal
11
Indonesia
11
Mozambique
10
Congo, Democratic Republic of
8
Burkina Faso
7
Guinea
7
Haiti
7
East and Southern Africa
7
Russia
7
Eswatini/ Swaziland
7
Cameroon
6
Pakistan
6
Albania
5
Middle East and North Africa
5
Eastern Europe and Central Asia
5
Georgia
5
Tajikistan
4
Thailand
4
Syria
4
Laos
4
Venezuela
4
Germany
4
West and Central Africa
4
Western Pacific Region
4
Vietnam
4
Moldova
4
Benin
3
Afghanistan
3
Armenia
3
Paraguay
3
Sudan
3
South Sudan
3
North Macedonia
2
Jordan
2
Jamaica
2
Sri Lanka
2
Central African Republic
2
Colombia
1
Timor Leste/ East Timor
1
Turkey
1
Gambia
1
China
1
Kazakhstan
1
Kyrgyzstan
1
Uzbekistan
1
Peru
1
Mongolia
1
Qatar
1
Bulgaria
1
USA
1
North America
1
Belgium
1
Côte d’Ivoire / Ivory Coast
1
Bolivia
1
Papua New Guinea
1
Brazil
1
Honduras
1
Libya
1
Somalia
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
792
Public Health
103
Clinical Guidelines
72
Women & Child Health
49
Key Resources
32
Pharmacy & Technologies
12
Capacity Building
7
Toolboxes
TB
211
HIV
201
Mental Health
86
AMR
72
COVID-19
53
Pharmacy
43
Health Financing Toolbox
33
NCDs
29
Global Health Education
29
NTDs
28
Planetary Health
26
Caregiver
23
Ebola
20
Rapid Response
15
Disability
15
Conflict
14
Refugee
12
Polio
11
Natural Hazards
4
Social Ethics
3
Zika
2
Cholera
1
Health Financing
1
The report aims to capture lessons from the COVID-19 pandemic and to highlight the opportunity for more ambitious global action: expanding sustainable access to vaccines for all towards the Immunization Agenda 2030 and pandemic prevention, preparedness and response efforts. The report is organized i...
This checklist is for any organization or person supporting the routine use of evidence in
the process of policy-making. Evidence-informed policy-making (EIPM) is essential for achieving the Sustainable Development Goals (SDGs) and universal health coverage (UHC). Its importance is emphasized in WH...
The Country Cooperation Strategy is the World Health Organization’s corporate framework developed in response to a country’s needs and priorities. The 2022–2025 CCS is the fourth for WHO in Sierra Leone. It is a medium-term strategic document that defines a broad framework for WHO’s work, at...
The Quadripartite organizations have developed the One Health Priority Research Agenda for AMR report, this is a joint initiative to assist in directing and catalysing scientific interest and financial investments for the priority research agenda across sectors for countries and funding bodies. The ...
CEPI is seeking to raise $3.5 billion to implement CEPI’s next 5-year plan. To mitigate the immediate threat of COVID-19 variants, it is activating key elements of this plan now—and seeking to mobilise a portion of this $3.5 billion in 2021. We have already launched R&D programmes to initiate de...
Development finance institutions owned by European governments and the World Bank Group are spending hundreds of millions of dollars on expensive for-profit hospitals in the Global South that block patients from getting care, or bankrupt them, with some even imprisoning patients who cannot afford th...
Over the 20 years that followed, this unique partnership has invested more than US$53 billion, saving 44 million lives and reducing the combined death rate from the three diseases by more than half in the countries in which the Global Fund invests.
This report makes clear that there is a path to end AIDS. Taking that path will help ensure preparedness to address other pandemic challenges, and advance progress across the Sustainable Development Goals. The data and real-world examples in the report make it very clear what that path is. It is not...
Antimicrobial resistance (AMR) is a global human, animal, plant and environment health threat that needs to be addressed by every country. The impacts of AMR are wide-ranging in terms of human health, animal health, food security and safety, environmental effects on ecosystems and biodiversity, and ...
This report summarizes the World Health Organization’s (WHO) global work on water, sanitation and hygiene (WASH) during 2022. It describes how the Organization continued to deliver its essential WASH programming as elaborated in its 2018–2025 strategy.
WHO/Europe has launched a new guide, providing support to countries on how to apply behavioural and cultural insights (BCI) for health. It presents a simple step-wise approach, complemented by a rich collection of detailed considerations, tools and exercises. The guide is the first of its kind, spec...
Significant progress has been made in the eradication of three priority diseases in the African Region, as a result of extensive collaboration between the Regional Office, WHO country offices and countries. For example, in August 2020, the region was certified free of wild poliovirus. In the area of...
Prompt, effective antimalarial treatment, and supportive care can substantially reduce the rate of mortality from severe malaria. However, many children in malaria-endemic countries do not have access to health facilities or a qualified health care provider and do not receive the necessary care in a...
Background: Cardiovascular disease (CVD), mainly heart attack and stroke, is the
leading cause of premature mortality in low and middle income countries (LMICs).
Identifying and managing individuals at high risk of CVD is an important strategy to prevent and control CVD, in addition to multisector...
More than 40% of the world population is 24 years old or younger, the vast majority of whom live in low- and lower middle–income countries. Globally, a quarter of disability-adjusted life years (DALYs) for mental disorders and substance abuse is borne by this age group and about 75% of mental diso...
Vaccines are powerful weapons in the fight against pandemic viruses as shown by responses to both the 2009 H1N1 influenza and the COVID-19 pandemics. However, planning for accessing, allocating and deploying vaccines in a pandemic situation is a complex endeavour, beset with multiple challenges at a...
Objective: To identify gaps in national stroke guidelines that could be bridged to enhance the quality of stroke care services in low- and
middle-income countries.
Methods: We systematically searched medical databases and websites of medical societies and contacted international organizations.
Co...
As the Americas undergo profound demographic change and there are more persons aged 65 years or older than children younger than 5 years, it is crucial to recognize that national immunization programs must be redesigned to ensure comprehensive protection for individuals across the lifespan. By adopt...
The purpose of this workbook is to assist ministries of health, health managers and practitioners in engaging with the private sector on delivery of quality maternal, newborn and child health (MNCH) services in lower- and middle-income countries. Private health care is one of the fastest growing seg...
This Guidance was developed in response to the increase in HIV-related human rights crises and the shrinking civic space for rights-related responses to HIV in recent years across the world. This document builds upon existing guidance documents, offering updated guidance for country-based United Nat...
